A detailed history of Ancora Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 1,000 shares of NBIX stock, worth $125,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$125,000
Previous $137,000 16.06%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $130,860 - $143,190
1,000 New
1,000 $137,000
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $1,591 - $2,101
21 New
21 $2,000
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $3,705 - $4,258
-43 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $3,845 - $4,397
43 New
43 $4,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.